Is pomalidomide available in China? Is it included in medical insurance?

Pomalidomide is often used in combination with other drugs (such as dexamethasone), especially in patients with multiple myeloma who have received at least two other treatments that have not responded well and whose disease has progressed after the last treatment. It blocks the growth and spread of tumors by interfering with the DNA replication and transcription processes of tumor cells, enhances the function of the immune system, and improves the body's ability to recognize and eliminate tumor cells. The recommended dose and duration of pomalidomide should be determined based on the patient's specific condition and the doctor's advice.

Multiple myeloma is a severe hematological malignancy that originates from plasma cells in the bone marrow. These cells proliferate abnormally and form tumors, leading to a series of complications such as bone destruction, anemia, and renal damage. Pomalidomide is an effective treatment for multiple myeloma. It belongs to the class of immunomodulators and inhibits the growth and spread of tumor cells by affecting specific signaling pathways within cells.

However, the use of pomalidomide may also be associated with a series of side effects, such as fatigue, nausea, diarrhea, rash, hematological toxicity, etc. Therefore, when pomalidomide is used to treat multiple myeloma, the patient's physical condition needs to be closely monitored and the treatment plan adjusted in a timely manner to ensure the safety and effectiveness of the treatment.

Pomalidomide has been launched in China and has been included in the medical insurance reimbursement items.The reimbursed price of 4mg*21 tablets is about 5,000 yuan. The specific reimbursement ratio varies by region, so you need to consult the local medical insurance reimbursement department. In overseas markets, the price of generic drugs of the same specifications is lower, about 650 yuan from ASEAN Pharmaceuticals in Laos and about 2,200 yuan from NATCO in India. If you need to know more about pomalidomide, please consult a regular overseas medical consulting agency.

xa0

Reference materials:https://www.drugs.com/mtm/pomalidomide.html